|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang H, Yang T and Wu X: 5-Fluorouracil
preferentially sensitizes mutant KRAS non-small cell lung carcinoma
cells to TRAIL-induced apoptosis. Mol Oncol. 9:1815–1824. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He X, Li C, Wu X and Yang G: Docetaxel
inhibits the proliferation of non-small-cell lung cancer cells via
upregulation of microRNA-7 expression. Int J Clin Exp Pathol.
8:9072–9080. 2015.PubMed/NCBI
|
|
4
|
Heigener DF, Kerr KM, Laing GM, Mok TSK,
Moiseyenko FV and Reck M: Redefining treatment paradigms in
first-line advanced Non-small-cell lung cancer. Clin Cancer Res.
25:4881–4887. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noro R, Miyanaga A, Minegishi Y, Okano T,
Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A and Gemma A:
Histone deacetylase inhibitor enhances sensitivity of
non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of
thymidylate synthase expression and up-regulation of p21(waf1/cip1)
expression. Cancer Sci. 101:1424–1430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Hou N, Faried A, Tsutsumi S,
Takeuchi T and Kuwano H: Inhibition of autophagy by 3-MA enhances
the effect of 5-FU-induced apoptosis in colon cancer cells. Ann
Surg Oncol. 16:761–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi H, Cho HJ, Cho SM, Jo K, Park JA, Lee
SH, Chang BJ, Kim JS and Shin HC: Effect of 5-FU and MTX on the
expression of drug-resistance related cancer stem cell markers in
non-small cell lung cancer cells. Korean J Physiol Pharmacol.
16:11–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan X, Zhang X, Sun H, Zhang J, Yan M and
Zhang H: Autophagy inhibition promotes 5-fluorouraci-induced
apoptosis by stimulating ROS formation in human non-small cell lung
cancer A549 cells. PLoS One. 8:e566792013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oguri T, Bessho Y, Achiwa H, Ozasa H,
Maeno K, Maeda H, Sato S and Ueda R: MRP8/ABCC11 directly confers
resistance to 5-fluorouracil. Mol Cancer Ther. 6:122–127. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berezikov E, Chung WJ, Willis J, Cuppen E
and Lai EC: Mammalian mirtron genes. Mol Cell. 28:328–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hara ES, Ono M, Eguchi T, Kubota S, Pham
HT, Sonoyama W, Tajima S, Takigawa M, Calderwood SK and Kuboki T:
miRNA-720 controls stem cell phenotype, proliferation and
differentiation of human dental pulp cells. PLoS One. 8:e835452013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Holmstrom K, Qiu W, Ditzel N, Shi
K, Hokland L and Kassem M: MicroRNA-34a inhibits osteoblast
differentiation and in vivo bone formation of human stromal stem
cells. Stem Cells. 32:902–912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Jiang M and Xia S: miR-339-5p
increases radiosensitivity of lung cancer cells by targeting
phosphatases of regenerating liver-1 (PRL-1). Med Sci Monit.
24:8408–8416. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang B, Jing C, Wang J, Guo X, Chen Y, Xu
R, Peng L, Liu J and Li L: Identification of microRNAs associated
with lymphangiogenesis in human gastric cancer. Clin Transl Oncol.
16:374–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Q, Lu G, Cai Y, Li Y, Xu R, Ke Y and
Zhang S: MiR-124-5p inhibits the growth of high-grade gliomas
through posttranscriptional regulation of LAMB1. Neuro Oncol.
16:637–651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jinushi T, Shibayama Y, Kinoshita I,
Oizumi S, Jinushi M, Aota T, Takahashi T, Horita S, Dosaka-Akita H
and Iseki K: Low expression levels of microRNA-124-5p correlated
with poor prognosis in colorectal cancer via targeting of SMC4.
Cancer Med. 3:1544–1552. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He W, He S, Wang Z, Shen H, Fang W, Zhang
Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated gene-1
(AEG-1) induces epithelial-mesenchymal transition in lung cancer
through activating Wnt/β catenin signaling. BMC Cancer. 15:1072015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen
D, Forcier T, Shah K, Saxena U, Hansen U, Fisher PB and Sarkar D:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang P, Yin B, Shan L, Zhang H, Cui J,
Zhang M and Song Y: RNA interference-mediated knockdown of
astrocyte elevated gene-1 inhibits growth, induces apoptosis, and
increases the chemosensitivity to 5-fluorouracil in renal cancer
Caki-1 cells. Mol Cells. 37:857–864. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao JG, Ren KM and Tang J: Overcoming
5-Fu resistance in human non-small cell lung cancer cells by the
combination of 5-Fu and cisplatin through the inhibition of glucose
metabolism. Tumor Biol. 35:12305–12315. 2014. View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Li H, Han J and Zhang Y:
Down-regulation of microRNA-124 is correlated with tumor metastasis
and poor prognosis in patients with lung cancer. Int J Clin Exp
Pathol. 8:1967–1972. 2015.PubMed/NCBI
|
|
26
|
Chang A: Chemotherapy, chemoresistance and
the changing treatment landscape for NSCLC. Lung Cancer. 71:3–10.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lei L, Huang Y and Gong W: miR-205
promotes the growth, metastasis and chemoresistance of NSCLC cells
by targeting PTEN. Oncol Rep. 30:2897–2902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z,
Zhang L, Yang Y, Zhu X, Zhang H, et al: Simultaneous overactivation
of Wnt β-catenin and TGF β signalling by miR-128-3p confers
chemoresistance-associated metastasis in NSCLC. Nat Commun.
8:158702017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou LK, Ma YS, Han Y, Lu GX, Luo P, Chang
ZY, Xie RT, Yang HQ, Chai L, Cai MX, et al: Association of
microRNA-33a molecular signature with non-small cell lung cancer
diagnosis and prognosis after chemotherapy. PLoS One.
12:e01704312017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo P, Yang Q, Cong LL, Wang XF, Li YS,
Zhong XM, Xie RT, Jia CY, Yang HQ, Li WP, et al: Identification of
miR124a as a novel diagnostic and prognostic biomarker in nonsmall
cell lung cancer for chemotherapy. Mol Med Rep. 16:238–246. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu J, Zhan Y, Feng J, Luo J and Fan S:
MicroRNAs associated with therapy of non-small cell lung cancer.
Int J Biol Sci. 14:390–397. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang M, Meng B and Liu Y, Yu J, Chen Q and
Liu Y: MiR-124 inhibits growth and enhances radiation-induced
apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell
Physiol Biochem. 44:2017–2028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao
R and Cui L: The tumor suppressor miR-124 inhibits cell
proliferation by targeting STAT3 and functions as a prognostic
marker for postoperative NSCLC patients. Int J Oncol. 46:798–808.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao X, Lu C, Chu W, Zhang B, Zhen Q, Wang
R, Zhang Y, Li Z, Lv B, Li H and Liu J: MicroRNA-124 suppresses
proliferation and glycolysis in non-small cell lung cancer cells by
targeting AKT-GLUT1/HKII. Tumour Biol. 39:10104283177062152017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi X and Wang X: The role of MTDH/AEG-1
in the progression of cancer. Int J Clin Exp Med. 8:4795–4807.
2015.PubMed/NCBI
|
|
36
|
Meng X, Thiel KW and Leslie KK: Drug
resistance mediated by AEG-1/MTDH/LYRIC. Adv Cancer Res.
120:135–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu S, Xu J, Xu X, Hu S, Li B and Li W: The
expression of astrocyte elevated gene-1 in human non-small-cell
lung cancer and its relationship with postoperative chemotherapy
and radiotherapy. Histopathology. 67:817–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Y, Wu J, Guan H, Cai J, Fang L, Li J
and Li M: MiR-136 promotes apoptosis of glioma cells by targeting
AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
